RxDoctor Payments Data

Stacey Miller-Smith, MD

Physical Medicine & Rehabilitation · Princeton, NJNPI 1578712956

Payments from drug & device makers

$253in general payments, 2019–2025

Across 13 payments — averaging $19.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$158
  • Electronic Waveform Lab, Inc.$35
  • Pfizer$15
  • Vertical Pharmaceuticals, LLC$15
  • Ferring Pharmaceuticals Inc.$15
  • Sanofi-aventis U.S. LLC$14

What the payments were for

  • Food & beverage$253100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson7$158
Electronic Waveform Lab, Inc.2$35
Pfizer1$15
Vertical Pharmaceuticals, LLC1$15
Ferring Pharmaceuticals Inc.1$15
Sanofi-aventis U.S. LLC1$14

How this compares

$253 in reported general payments places this provider in the 50th percentile of 434 physical medicine & rehabilitation providers in New Jersey.

See all physical medicine & rehabilitation providers in New Jersey

Medicare billing

Part B allowed, 2024
$317,455
Medicare patients
657
Services billed
4,132

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban32$16,818
JardianceEmpagliflozin13$7,684
Gabapentin212$3,551
Fentanyl27$2,656
Lubiprostone13$1,816
Atorvastatin Calcium101$1,228
Tizanidine Hcl46$903
Lidocaine16$864
Metoprolol Succinate38$789
Mirtazapine19$782
Diclofenac Sodium19$754
Oxycodone Hcl40$666
Ranolazine ErRanolazine13$531
Celecoxib17$417
Duloxetine Hcl17$401

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$15$16,81832 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 434 physical medicine & rehabilitation providers in New Jersey.

Other physical medicine & rehabilitation in Princeton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →